ArticleCurrent medicinal chemistry2025

Multitargeted Docking, DFT-Based Optimisation, Pharmacokinetics, and MD Simulation Reveal 6-Oxidopamine HBr as a Multitargeted Inhibitor of Cervical Cancer Proteins.

Youssef Saeed Alghamdi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.